Status:
ACTIVE_NOT_RECRUITING
Histotripsy (HistoSonics®) for Liver Tumours
Lead Sponsor:
The University of Hong Kong
Conditions:
Liver Tumour
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Histotripsy is a promising non-invasive technique that uses high-intensity ultrasound waves to disrupt tissue without damaging surrounding structures. It works by using high-intensity ultrasound waves...
Eligibility Criteria
Inclusion
- Fit for general anaesthesia
- Liver tumour size \< 10cm
- Solitary or multifocal
- Primary liver tumour such as hepatocellular carcinoma or intrahepatic cholangiocarcinoma
- Secondary liver tumour such as liver metastasis
- Patients with operable or inoperable liver tumours
- Liver transplant candidates awaiting for liver graft
Exclusion
- Refusal to take part in clinical trial
- Child C liver cirrhosis
- Not fit for general anaesthesia
Key Trial Info
Start Date :
August 29 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2028
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06579833
Start Date
August 29 2024
End Date
September 1 2028
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong
Hong Kong, Hong Kong, 0000